Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Novartis AG

WKN: A41250 / Name: Novartis / Stock / ? /

?
-1.050%

Novartis AG

WKN: A40CPF / Name: Novartis / Stock / ? /

?
-0.550%

Novartis AG

WKN: 904278 / Name: Novartis / Stock / Pharmaceuticals / Large Cap /

€136.92
-0.940%

Novartis AG ADR

WKN: 907122 / Symbol: NVS / Name: Novartis / Stock / Pharmaceuticals / Large Cap /

€136.00
-2.160%

Novartis Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Novartis Q2 Earnings Call Highlights

Key Points

Novartis Aktie: Chai Discovery für KI-WirkstoffsuchePhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Novartis Aktie: Chai Discovery für KI-Wirkstoffsuche

Novartis rüstet technologisch auf. Der Pharmariese setzt bei der Suche nach neuen Medikamenten künftig…

Der Beitrag Novartis Aktie: Chai Discovery für KI-Wirkstoffsuche erschien zuerst auf kapitalma

Novartis Aktie: Zahlen am 21. JuliPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Novartis Aktie: Zahlen am 21. Juli

Juli 2026 seine Zahlen zum zweiten Quartal vor. Für Anleger steht dabei mehr auf…

Der Beitrag Novartis Aktie: Zahlen am 21. Juli erschien zuerst auf kapitalmarktexperten.de.

Quelle kapitalmarktexper

Novartis Q2 Earnings & Revenues Top Estimates, Key Drugs Perform WellPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Novartis Q2 Earnings & Revenues Top Estimates, Key Drugs Perform Well

Swiss pharma giant Novartis AG NVS reported second-quarter core earnings per share (excluding one-time charges) of $2.41, which comfortably beat the Zacks Consensus Estimate of $2.20. The figure

Novartis verzeichnete im zweiten Quartal Umsatzsteigerungen und baute die Pipeline weiter aus; Prognose für das Geschäftsjahr bekräftigtPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Novartis verzeichnete im zweiten Quartal Umsatzsteigerungen und baute die Pipeline weiter aus; Prognose für das Geschäftsjahr bekräftigt

Ad-hoc-Mitteilung gemäss Art. 53 KR

Zweites Quartal

  • Der Nettoumsatz stieg um 1% (kWk1, 3% USD), das operative Kernergebnis1 blieb unverändert (kWk und USD)
    • Das Umsatzwachstum beruhte auf den
Company News for July 22, 2026
Company News for July 22, 2026
  • Novartis AG’s NVS shares grew 2.9% after reporting second-quarter 2026 revenues of $14.41 billion, beating the Zacks Consensus Estimate of $13.95 billion.
  • Shares of General Motors Company GM gained
Varta AG

WKN: A0TGJ5 / Name: Varta / Stock / Mid Cap /

€1.23
0.320%

Noratis AG

WKN: A2E4MK / Name: Noratis / Stock / Small Cap /

€0.050
-21.260%

Novartis Finance S.a.

WKN: A1ZR5A / Name: Novartis Finance S.a. / Stock / ? /

€99.63
0.050%

Novartis Capital Corp.

WKN: A18U7A / Name: Novartis Capital Corp. / Stock / ? /

€84.56
0.810%

Novartis Capital Corp.

WKN: A28TTE / Name: Novartis Capital Corp. / Stock / ? /

€92.90
0.260%

Novartis Finance S.a.

WKN: A19WB8 / Name: Novartis Finance S.a. / Stock / ? /

€83.37
0.280%

Noratis AG

WKN: A3H2TV / Name: Noratis / Stock / ? /

€16.62
1.670%

Novartis Finance S.a.

WKN: A282SQ / Name: Novartis Finance S.a. / Stock / ? /

€93.88
0.040%

Novartis Finance S.a.

WKN: A19FG5 / Name: Novartis Finance S.a. / Stock / ? /

€98.39
0.020%

Novartis Finance S.a.

WKN: A19WB7 / Name: Novartis Finance S.a. / Stock / ? /

€95.17
0.170%